Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Short Communication
Authors: Clark, Ian A.a; * | Alleva, Lisa M.a | Vissel, Bryceb
Affiliations: [a] Research School of Biology, Australian National University, Canberra, Australia | [b] Neurodegeneration Research Group, Garvan Institute, Sydney, Australia
Correspondence: [*] Correspondence to: Ian A. Clark, Research School of Biology, Building 41, Australian National University, Canberra ACT 0200, Australia. Tel.: +61 2 6125 4363; Fax.: +61 2 6125 0313; E-mail: [email protected].
Abstract: Both tumor necrosis factor (TNF) and leptin are, independently, under investigation as the central mechanism for Alzheimer's disease. The wider literature provides every indication that both mediators are part of the same pathways thought to cause functional loss in this condition. This association, which has not been specifically addressed in the Alzheimer's disease literature, may be a useful link to expedite future study into the pathogenesis of this condition.
Keywords: Alzheimer's disease, inflammation, leptin, tumor necrosis factor
DOI: 10.3233/JAD-2011-110266
Journal: Journal of Alzheimer's Disease, vol. 26, no. 2, pp. 201-205, 2011
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]